Literature DB >> 19129179

Anionic phospholipids lose their procoagulant properties when incorporated into high density lipoproteins.

Cecilia Oslakovic1, Michael J Krisinger, Astra Andersson, Matti Jauhiainen, Christian Ehnholm, Björn Dahlbäck.   

Abstract

Blood coagulation involves a series of enzymatic protein complexes that assemble on the surface of anionic phospholipid. To investigate whether apolipoproteins affect coagulation reactions, they were included during the preparation of anionic phospholipid vesicles using a detergent solubilization-dialysis method. Apolipoprotein components of high density lipoproteins, especially apolipoprotein A-I, had a pronounced anticoagulant effect. The anionic phospholipids lost their procoagulant effect when the vesicle preparation method was performed in the presence of apolipoprotein A-I. The anionic phospholipid-apolipoprotein A-I particles were 8-10 nm in diameter and contained around 60-80 phospholipid molecules, depending on the phospholipid composition. The phospholipids of these particles were unable to support the activation of prothrombin by factor Xa in the presence of factor Va and unable to support binding of factor Va, whereas binding of prothrombin and factor Xa were efficient. Phospholipid transfer protein was shown to mediate transfer of phospholipids from liposomes to apolipoprotein A-I-containing reconstituted high density lipoprotein. In addition, serum was also shown to neutralize the procoagulant effect of anionic liposomes and to efficiently mediate transfer of phospholipids from liposomes to either apolipoprotein A-I- or apolipoprotein B-containing particles. In conclusion, apolipoprotein A-I was found to neutralize the procoagulant properties of anionic phospholipids by arranging the phospholipids in surface areas that are too small to accommodate the prothrombinase complex. This anionic phospholipid scavenger function may be an important mechanism to control the exposure of such phospholipids to circulating blood and thereby prevent inappropriate stimulation of blood coagulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19129179     DOI: 10.1074/jbc.M807286200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

Review 1.  The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?

Authors:  Menno Vergeer; Adriaan G Holleboom; John J P Kastelein; Jan Albert Kuivenhoven
Journal:  J Lipid Res       Date:  2010-04-06       Impact factor: 5.922

Review 2.  Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism.

Authors:  John J Albers; Simona Vuletic; Marian C Cheung
Journal:  Biochim Biophys Acta       Date:  2011-06-28

3.  Reevaluation of the role of HDL in the anticoagulant activated protein C system in humans.

Authors:  Cecilia Oslakovic; Eva Norstrøm; Björn Dahlbäck
Journal:  J Clin Invest       Date:  2010-05       Impact factor: 14.808

Review 4.  Impact of Phospholipid Transfer Protein in Lipid Metabolism and Cardiovascular Diseases.

Authors:  Xian-Cheng Jiang
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

5.  Plasma Phospholipid Transfer Protein Promotes Platelet Aggregation.

Authors:  Xiao-Min Zhao; Yun Wang; Yang Yu; Hui Jiang; Anna Babinska; Xiu-Yu Chen; Ke-Gui He; Xiang-Dong Min; Ji-Ju Han; Chen-Xi Yang; Kevin Deng; Jing Xue; Xiangjian Zhang; Guo-Hua Song; Shu-Cun Qin; Xian-Cheng Jiang
Journal:  Thromb Haemost       Date:  2018-11-12       Impact factor: 5.249

Review 6.  Phospholipid transfer protein: its impact on lipoprotein homeostasis and atherosclerosis.

Authors:  Xian-Cheng Jiang
Journal:  J Lipid Res       Date:  2018-02-08       Impact factor: 5.922

Review 7.  Progress in HDL-based therapies for atherosclerosis.

Authors:  Kuang-Yuh Chyu; Anish Peter; Prediman K Shah
Journal:  Curr Atheroscler Rep       Date:  2011-10       Impact factor: 5.113

Review 8.  High density lipoproteins are modulators of protease activity: Implications in inflammation, complement activation, and atherothrombosis.

Authors:  Scott M Gordon; Alan T Remaley
Journal:  Atherosclerosis       Date:  2016-11-16       Impact factor: 5.162

9.  Modeling the time evolution of the nanoparticle-protein corona in a body fluid.

Authors:  Daniele Dell'Orco; Martin Lundqvist; Cecilia Oslakovic; Tommy Cedervall; Sara Linse
Journal:  PLoS One       Date:  2010-06-03       Impact factor: 3.240

10.  Annexin-II, DNA, and histones serve as factor H ligands on the surface of apoptotic cells.

Authors:  Jonatan Leffler; Andrew P Herbert; Eva Norström; Christoph Q Schmidt; Paul N Barlow; Anna M Blom; Myriam Martin
Journal:  J Biol Chem       Date:  2009-12-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.